Drug intelligence / Profile preview

chlorhexidine + cymenol gel

Development stage
Phase 4
Lead developer
Italfarmaco
Modality
Small Molecules
Administration
Topical
01

Overview

This experimental antimicrobial gel formulation, developed by researchers at the University of Santiago de Compostela, combines 0.20% chlorhexidine (CHX) with cymenol (o-cymen-5-ol). Chlorhexidine is a well-established cationic bisbiguanide antiseptic that disrupts bacterial cell membranes, while cymenol is a small molecule antimicrobial agent that provides complementary activity against oral biofilms. The formulation is specifically designed to target dental plaque and salivary flora. In a randomized crossover clinical trial involving healthy volunteers, a single application of the gel demonstrated potent immediate antimicrobial effects and substantivity (persistence of action) for up to seven hours, performing similarly to standard 0.20% chlorhexidine-only gels. It is currently being investigated for its efficacy in maintaining oral hygiene and preventing biofilm-related dental conditions.

Other names
0.20% CHX and Cymenol gelo-cymen-5-ol + chlorhexidine gelCHX + Cymenol gel
02

Targets

Bacterial cell wall and cytoplasmic membrane anionic components

Beyond the preview

Go deeper on chlorhexidine + cymenol gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorhexidine + cymenol gel.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call